Research Interests
I have published several papers focused on epidemiology of colorectal cancer in Saudi Arabia, index development for inflammatory bowel disease, drug development and personalized medicine with a focus on histologic disease activity as an outcome measure:
Published:
2012:
Mosli, M.H. and M.S. Al-Ahwal, Colorectal cancer in the Kingdom of Saudi Arabia: need for screening. Asian Pac J Cancer Prev, 2012. 13(8): p. 3809-13.
Mosli, M., et al., Nonutility of routine testing of stool for ova and parasites in a tertiary care Canadian centre. Can J Microbiol, 2012. 58(5): p. 653-9.
Mosli, M.H. and M.S. Al-Ahwal, Does the increasing trend of colorectal cancer incidence in jeddah reflect a rise in the kingdom of saudi arabia? Asian Pac J Cancer Prev, 2012. 13(12): p. 6285-8.
Mosli, M.H. and Feagan, B.G., The Emerging Role of Vedolizumab in The Treatment of Ulcerative Colitis; Review Article, Clinical Investigation, (2012) 2(12), 1201–1212
Mosli, M.H. and Beaton M.D., Case Report: Clozapine Induced Ogilvie’s Syndrome. J Gastrointest Digest Sys, (2012) 2:105. Doi: 10.4172/jgds.1000105
2013:
Mosli, M., J. Parfitt, and J. Gregor, A retrospective analysis of disease association and outcome in histologically confirmed ischemic colitis. J Dig Dis, 2013.
Mosli, M.H. and B.G. Feagan, Vedolizumab for Crohn's disease. Expert Opin Biol Ther, 2013. 13(3): p. 455-63.
Mosli, M., et al., The Effect of Liver Transplantation for Primary Sclerosing Cholangitis on Disease Activity in Patients with Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y), 2013. 9(7): p. 434-441.
Mosli, M.H., et al., The safety and efficacy of gastric fundal variceal obliteration using N-butyl-2-cyanoacrylate; the experience of a single canadian tertiary care centre. Saudi J Gastroenterol, 2013. 19(4): p. 152-9.
Khanna, R., M.H. Mosli, and B.G. Feagan, Challenging question: is treating inflammatory bowel disease an art or strictly an evidence-based matter? Dig Dis, 2013. 31(2): p. 213-7.
Mosli, M., et al., Therapeutic drug monitoring to assess clinical response to sedative medications in the intensive care unit: a case report and discussion. J Popul Ther Clin Pharmacol, 2013. 20(3): p. e305-11.
Teriaky, A., et al., The safety and efficacy of adalimumab in patients with Crohn's disease: the experience of a single Canadian tertiary care centre. Scand J Gastroenterol, 2013.
2014:
Mosli, M.H., et al., Histologic Evaluation of Ulcerative Colitis: A Systematic Review of Disease Activity Indices. Inflamm Bowel Dis, 2014.
Mosli, M.H., J. Rivera-Nieves, and B.G. Feagan, T-Cell Trafficking and Anti-Adhesion Strategies in Inflammatory Bowel Disease: Current and Future Prospects. Drugs, 2014.
Mosli, M.H., et al., Toward a personalized medicine approach to the management of inflammatory bowel disease. Am J Gastroenterol, 2014. 109(7): p. 994-1004.
Samaan, M.A., et al., A Systematic Review of the Measurement of Endoscopic Healing in Ulcerative Colitis Clinical Trials: Recommendations and Implications for Future Research. Inflamm Bowel Dis, 2014.
Mosli, M., et al., Advances in the diagnosis and management of inflammatory bowel disease: challenges and uncertainties. Saudi J Gastroenterol, 2014. 20(2): p. 81-101.
Mosli, M.H., B. Aljudaibi, and M. Al-Madi, Saudi gastroenterology association position statement on safety issues associated with the use of domperidone. Saudi J Gastroenterol, 2014. 20(5): p. 267-9.
Mosli, M.H., et al., Reproducibility of histological assessments of disease activity in UC. Gut, 2014.
2015:
Sandhu A, Mosli M, Yan B, Wu T, Gregor J, Chande N, Ponich T, Beaton M, Rahman A., Self-Screening for Malnutrition Risk in Outpatient Inflammatory Bowel Disease Patients Using the Malnutrition Universal Screening Tool (MUST). JPEN J Parenter Enteral Nutr, 2015.
Majid A Almadi, Mahmoud H. Mosli, Mohamed S Bohlega, Mohanned A Al Essa, Mohammed S AlDohan, Turki A Alabdallatif, Turki Y AlSagri, Faleh A Algahtani, Ahmed Mandil. Effect of public knowledge, attitudes, and behavior on willingness to undergo colorectal cancer screening using the health belief model. Saudi J Gastroenterol, 2015. 21(2): p. 71-7.
Mahmoud H. Mosli, John K. MacDonald, Stephen J. Bickston, Brian W. Behm, David J. Tsoulis, Jianfeng Cheng, Reena Khanna, Brian G. Feagan. Vedolizumab for Induction and Maintenance of Remission in Ulcerative Colitis: A Cochrane Systematic Review and Meta-analysis. Inflamm Bowel Dis Journal, 2015. 21(5): p. 1151-9
Parambir S. Dulai, Mahmoud Mosli, Reena Khanna, Barrett G. Levesque, William J. Sandborn, and Brian G. Feagan. Vedolizumab for the Treatment of Moderately to Severely Active Ulcerative Colitis. Pharmacotherapy, 2015. 35(4): p. 412-23.
Mahmoud H. Mosli, GY Zou, Sushil K Garg, Sean G Feagan, John K MacDonald, Nilesh Chande, William J Sandborn, Brian G Feagan. C-Reactive Protein, Fecal Calprotectin, And Stool Lactoferrin For Detection Of Endoscopic Activity In Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review And Meta-Analysis. Amer J Gastroentrology, 2015
Bandar Al-Judaibi, Roberto Hernandez-Alejandro, Julia Uhanova, Paul Marotta, Natasha Chandok, Mahmoud Mosli. Duct-to-Duct Biliary Anastomosis Yields Similar Outcomes to Roux-en-Y Hepaticojejunostomy in Liver Transplantation for Primary Sclerosing Cholangitis. Hepatitis Monthly, 2015
Mosli, M.H., et al., A Saudi Gastroenterology association position statement on the use of tumor necrosis factor-alfa antagonists for the treatment of inflammatory bowel disease. Saudi J Gastroenterol, 2015. 21(4): p. 185-97
Mosli, M.H. and B.G. Feagan, Combination therapy for the treatment of Crohn's disease. Expert Opin Biol Ther, 2015: p. 1-14.
In Press:
Reena Khanna, Mahmoud H. Mosli, Brian G. Feagan. Targeting Leukocyte Trafficking in IBD: What is the Clinical Evidence? Dig Dis, 2015
Vipul Jairath, Reena Khanna, M. Mosli, Larry Stitt, GY Zhou, Peggy Vandervoort, Barrett Levesque, William Sandborn, Brian Feagan. Development of Interim Patient Reported and Co-Primary Outcome Measures for the Assessment of Ulcerative Colitis in Clinical Trials – APT
L. Kwapisz, M. Mosli, N. Chande, B. Yan, M. Beaton, W. Barnett, K. Bax, T. Ponich, J. Howard, R. Lannigan, J. Gregor. The clinical use of fecal calprotectin in the diagnosis of inflammatory bowel disease – Saudi J Gastro